- Home
- Publications
- Publication Search
- Publication Details
Title
Antimitotic drugs in the treatment of cancer
Authors
Keywords
Taxanes, Epothilones, Vinca alkaloids, Estrogens, 2-Methoxyestradiol
Journal
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 76, Issue 6, Pages 1101-1112
Publisher
Springer Nature
Online
2015-11-12
DOI
10.1007/s00280-015-2903-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cyclin dependent kinase (CDK) inhibitors as anticancer drugs
- (2015) Concepción Sánchez-Martínez et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- p53 orchestrates calcium signalingin vivo
- (2015) Giovanni Sorrentino et al. CELL CYCLE
- The tubulysin analogue KEMTUB10 induces apoptosis in breast cancer cells via p53, Bim and Bcl-2
- (2015) Oluwafunmilayo F. Lamidi et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Peloruside A Inhibits Growth of Human Lung and Breast Tumor Xenografts in an Athymic nu/nu Mouse Model
- (2015) C. J. Meyer et al. MOLECULAR CANCER THERAPEUTICS
- Aneuploidy and chromosomal instability in cancer: a jackpot to chaos
- (2015) Maybelline Giam et al. Cell Division
- Folate–Vinca Alkaloid Conjugates for Cancer Therapy: A Structure–Activity Relationship
- (2014) Christopher P. Leamon et al. BIOCONJUGATE CHEMISTRY
- 17-beta-estradiol analog inhibits cell proliferation by induction of apoptosis in breast cell lines
- (2014) Michelle Helen Visagie et al. MICROSCOPY RESEARCH AND TECHNIQUE
- Evaluation of 2′,4′-dihydroxy-3,4,5-trimethoxychalcone as antimitotic agent that induces mitotic catastrophe in MCF-7 breast cancer cells
- (2014) Kamonporn Masawang et al. TOXICOLOGY LETTERS
- Molecular aspects of cancer cell resistance to chemotherapy
- (2013) Magali Rebucci et al. BIOCHEMICAL PHARMACOLOGY
- Tubulin inhibitors: a patent review
- (2013) Yi-Min Liu et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- PRECEDENT: A Randomized Phase II Trial Comparing Vintafolide (EC145) and Pegylated Liposomal Doxorubicin (PLD) in Combination Versus PLD Alone in Patients With Platinum-Resistant Ovarian Cancer
- (2013) R. Wendel Naumann et al. JOURNAL OF CLINICAL ONCOLOGY
- Synthesis and Biological Activity of 3-N-Substituted Estrogen Derivatives as Breast Cancer Agents
- (2013) Zhongliang Wan et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Signaling Pathways of ESE-16, an Antimitotic and Anticarbonic Anhydrase Estradiol Analog, in Breast Cancer Cells
- (2013) Barend Andre Stander et al. PLoS One
- Nanoparticle and targeted systems for cancer therapy
- (2012) Lisa Brannon-Peppas et al. ADVANCED DRUG DELIVERY REVIEWS
- MicroRNAs: Novel mediators of resistance to microtubule-targeting agents
- (2012) Arun Kanakkanthara et al. CANCER TREATMENT REVIEWS
- Cabazitaxel: More Than a New Taxane for Metastatic Castrate-Resistant Prostate Cancer?
- (2012) A. C. Mita et al. CLINICAL CANCER RESEARCH
- Minireview: G Protein-Coupled Estrogen Receptor-1, GPER-1: Its Mechanism of Action and Role in Female Reproductive Cancer, Renal and Vascular Physiology
- (2012) Edward J. Filardo et al. ENDOCRINOLOGY
- US Food and Drug Administration Approval Overview in Metastatic Breast Cancer
- (2012) Patricia Cortazar et al. JOURNAL OF CLINICAL ONCOLOGY
- Multicenter Trial of EC145 in Advanced, Folate-Receptor Positive Adenocarcinoma of the Lung
- (2012) Martin J. Edelman et al. Journal of Thoracic Oncology
- Review of hormonal treatment of breast cancer
- (2012) IH Abdulkareem et al. Nigerian Journal of Clinical Practice
- The chemotherapeutic agent paclitaxel inhibits autophagy through two distinct mechanisms that regulate apoptosis
- (2012) R A Veldhoen et al. ONCOGENE
- The European Medicines Agency Review of Cabazitaxel (Jevtana(R)) for the Treatment of Hormone-Refractory Metastatic Prostate Cancer: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use
- (2012) E. Pean et al. ONCOLOGIST
- In Vitro Evaluation of ESE-15-ol, an Estradiol Analogue with Nanomolar Antimitotic and Carbonic Anhydrase Inhibitory Activity
- (2012) Barend Andre Stander et al. PLoS One
- Induction of apoptosis in human ovarian cancer cells by new anticancer compounds, epothilone A and B
- (2012) Aneta Rogalska et al. TOXICOLOGY IN VITRO
- Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel -polymer micelles to overcome multi-drug resistance
- (2011) Feihu Wang et al. BIOMATERIALS
- Hypoxia decreased chemosensitivity of breast cancer cell line MCF-7 to paclitaxel through cyclin B1
- (2011) X.L. Dong et al. BIOMEDICINE & PHARMACOTHERAPY
- Cooperative Phosphorylation of FADD by Aur-A and Plk1 in Response to Taxol Triggers Both Apoptotic and Necrotic Cell Death
- (2011) M.-S. Jang et al. CANCER RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy
- (2011) P N Kelly et al. CELL DEATH AND DIFFERENTIATION
- Principles and Current Strategies for Targeting Autophagy for Cancer Treatment
- (2011) R. K. Amaravadi et al. CLINICAL CANCER RESEARCH
- Eribulin—A review of preclinical and clinical studies
- (2011) Umang Swami et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Carbonic anhydrase IX (CA9) modulates tumor-associated cell migration and invasion
- (2011) H.-J. Shin et al. JOURNAL OF CELL SCIENCE
- Recent Developments in Cancer Vaccines
- (2011) K. Palucka et al. JOURNAL OF IMMUNOLOGY
- Ixabepilone, a Novel Microtubule-Targeting Agent for Breast Cancer, Is a Substrate for P-Glycoprotein (P-gp/MDR1/ABCB1) but not Breast Cancer Resistance Protein (BCRP/ABCG2)
- (2011) H. Shen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression
- (2011) Stefania Nobili et al. MEDICINAL RESEARCH REVIEWS
- The proliferation rate paradox in antimitotic chemotherapy
- (2011) Timothy J. Mitchison MOLECULAR BIOLOGY OF THE CELL
- II-Tubulin and III-Tubulin Mediate Sensitivity to Peloruside A and Laulimalide, but not Paclitaxel or Vinblastine, in Human Ovarian Carcinoma Cells
- (2011) A. Kanakkanthara et al. MOLECULAR CANCER THERAPEUTICS
- Docking, Synthesis, and in vitro Evaluation of Antimitotic Estrone Analogs
- (2010) Andre Stander et al. Chemical Biology & Drug Design
- MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression
- (2010) Ming Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Multiple Drug Resistance Mechanisms in Cancer
- (2010) Bruce C. Baguley MOLECULAR BIOTECHNOLOGY
- Microtubule-binding agents: a dynamic field of cancer therapeutics
- (2010) Charles Dumontet et al. NATURE REVIEWS DRUG DISCOVERY
- Separase Is Recruited to Mitotic Chromosomes to Dissolve Sister Chromatid Cohesion in a DNA-Dependent Manner
- (2009) Yuxiao Sun et al. CELL
- Tumor Self-Seeding by Circulating Cancer Cells
- (2009) Mi-Young Kim et al. CELL
- Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer
- (2009) Philippe L. Bedard et al. Nature Reviews Clinical Oncology
- Cancer cell apoptotic pathways mediated by PEDF: prospects for therapy
- (2009) Matthew L. Broadhead et al. TRENDS IN MOLECULAR MEDICINE
- Cardiac Toxicity in Breast Cancer Survivors: Review of Potential Cardiac Problems
- (2008) B. R.J. H. Bird et al. CLINICAL CANCER RESEARCH
- Linking Kinetochore-Microtubule Binding to the Spindle Checkpoint
- (2008) Daniel J. Burke et al. DEVELOPMENTAL CELL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started